What, if any, are some anticipated ethical challenges associated with the adoption of cffDNA screening? For example, will there be issues with accessibility to screening? Is there a fear of increased abortion rates? Is it advantageous/disadvantageous to know aneuploidy results earlier when there aren't corrective therapies besides pregnancy termination?
Q&A has ended
Serena Chen, MD
Director of Reproductive Medicine at IRMS
- All Questions & Answers
- Question: Ethical implications of improved screening methods?